FILLMED, formerly Filorga Medical, has launched the NANOSOFT, an intradermal implantation device that the company explains sits in between a mesotherapy and microneedling device.
According to the company, the NANOSOFT delivers the company’s patented formula NCTF which contains 59 active ingredients plus hyaluronic acid. It features three microneedles of 0.6mm depth made from crystal silicone which creates micro wounds to stimulate cellulate communication and the wound healing response.
During this, NCTF is delivered to treat indications such as fine lines, wrinkles, tonicity, pigmentation and pore size reduction, the company states. The product is distributed exclusively by FILLMED and laboratory Cosmedi Ltd.